+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
VEERHEALTH VEERHEALTH

Veerhealth Care Share Price

₹44.10 +0.11 (0.25%)
New 52W High in past week

07 Aug, 2026 4:00 PM (IST)

Veerhealth Care live price: ₹44.10. It opened at ₹44 vs previous close ₹44; intraday high/low: ₹44/₹44. The 50 & 200 DMA stand at ₹35.40/₹25.60.

Veerhealth Care Performance

  • Today's Low
  • ₹44
  • Today's High
  • ₹44
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹44
  • Open Price₹44
  • Previous Close₹44
  • Volume100,163
  • 50 DMA₹35.40
  • 100 DMA₹30.10
  • 200 DMA₹25.60

Veerhealth Care Chart

Investment Returns

  • Over 1 Month + 29.97%
  • Over 3 Month + 108.61%
  • Over 6 Month + 149.29%
  • Over 1 Year + 100.18%

Smart Investing Starts Here Start SIP with Veerhealth Care for Steady Growth!

Invest Now

Veerhealth Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 162.1
  • PEG Ratio
  • 4.2
  • Market Cap Cr
  • 88
  • P/B Ratio
  • 3.8
  • Average True Range
  • 1.1
  • EPS
  • 0.3
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.8
  • RSI
  • 94.35
  • MFI
  • 84.41

Latest Stock News Updates

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

The Company wishes to inform that it has received an order worth Rs. 5.27 Crores for supply of skincare products and enclosed is the press release of the same

Veerhealth Care Ltd - 511523 - Board Meeting Intimation for Consideration And Approval Of Financials For Quarter Ended June, 2026

Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. To consider and approve unaudited financial results of the Company for the quarter ended 30th June, 2026. 2. To approve draft Director's Report for the financial year ending 31st March, 2026. 3. To approve draft notice convening 34th Annual General Meeting of the Company. 4. Any other business with permission of the Chair.

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

The Company wishes to inform about the receipt of order from one of the largest FMCG Company for supply of skincare products for a value of Rs. 526.84 Lakhs

Veerhealth Care Financials

Veerhealth Care Technicals

EMA & SMA

Current Price
₹44.10
+ 0.11 (0.25%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹40.90
  • 50 Day
  • ₹35.40
  • 100 Day
  • ₹30.10
  • 200 Day
  • ₹25.60

Resistance and Support

43.9 Pivot Speed
  • R3 44.70
  • R2 44.40
  • R1 44.20
  • S1 43.70
  • S2 43.40
  • S3 43.20

Veerhealth Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-13 Quarterly Results
2026-05-30 Audited Results & Dividend
2026-03-28 Preferential Issue of shares Inter alia, to consider 1. Proposal for raising of funds by way of issue of one or more instruments including equity shares/convertible securities either by way of Preferential Issue or any other mode
2026-02-14 Quarterly Results
2025-11-12 Quarterly Results
Date Purpose Remarks
2016-11-30 Split Consolidation of equity shares from Re. 1/- to Rs. 10/-.
2005-10-05 Split Stock split from Rs. 10/- to Rs. 1/-
Date Purpose Remarks
2023-09-22 Bonus Bonus issue in the ratio of 1:1 of Rs. 10/-.

Veerhealth Care Shareholding Pattern

68.1%
31.91%
0%

Veerhealth Care FAQs

Veerhealth Care share price is ₹44 As on 07 August, 2026 | 16:54

The Market Cap of Veerhealth Care is ₹88.2 Cr As on 07 August, 2026 | 16:54

The P/E ratio of Veerhealth Care is 162.1 As on 07 August, 2026 | 16:54

The PB ratio of Veerhealth Care is 3.8 As on 07 August, 2026 | 16:54

The 52 week High & Low of Veerhealth Care is ₹44.2/₹16.7 respectively As on 07 August, 2026 | 16:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23